VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
VIRX
Delisted
VIRX was delisted on the 3rd of February, 2025.
49 hedge funds and large institutions have $42.5M invested in Viracta Therapeutics, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 16 increasing their positions, 10 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
9% more funds holding
Funds holding: 45 → 49 (+4)
Holders
49
Holding in Top 10
3
Calls
$134K
Puts
$32K
Top Buyers
| 1 | +$5M | |
| 2 | +$2.33M | |
| 3 | +$1.94M | |
| 4 |
ACM
Aisling Capital Management
New York
|
+$1.8M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$1.54M |
Top Sellers
| 1 | -$1.21M | |
| 2 | -$414K | |
| 3 | -$214K | |
| 4 |
Wells Fargo
San Francisco,
California
|
-$162K |
| 5 |
Renaissance Technologies
New York
|
-$125K |